Hims & Hers Health (HIMS) Q3 2024 Earnings
HIMS·Reported November 4, 2024·After market close
Hims & Hers Health reported Q3 2024 revenue of $401.6M, missed analyst consensus of $469.5M by $67.9M. Diluted EPS came in at $0.06.
Revenue
$401.6Mmissed by $67.9M
Consensus: $469.5MDiluted EPS
$0.06met estimate
Consensus: $0.06
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Hims & Hers Health's Q3 2024 earnings report.
Hims & Hers Health (HIMS) reported Q3 2024 earnings on November 4, 2024 after market close.
Hims & Hers Health reported revenue of $401.6M and diluted EPS of $0.06 for Q3 2024.
Revenue missed the consensus estimate of $469.5M by $67.9M. EPS beat the consensus estimate of $0.06 by $0.00.
You can read the 10-Q periodic report (0001773751-24-000339) directly on SEC EDGAR. The filing index links above go to sec.gov.